Release Date: 04/05/16 09:32 Summary: Corporate Update-IGS.AX Price Sensitive: No Download Document 379.36KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%